Subscribe to the BioNews newsletter for free

Advanced Search

Search for

Like the Progress Educational Trust on Facebook


Early genetic events in Down's syndrome revealed

08 September 2008

By Dr Rebecca Robey

Appeared in BioNews 474

Scientists have discovered the earliest genetic changes that occur in Down's syndrome, resulting in the abnormal development of the fetus and eventually leading to the host of medical complications associated with the disorder. The findings, published in the American Journal of Human Genetics, are a step forward in our understanding of the molecular basis of this complex condition, and may pave the way for improved therapies.

Down's syndrome is a genetic disorder that is seen in approximately 1 in every thousand children born in the UK and is on the rise in the developed world as a result of increasing maternal age. It arises from a genetic abnormality known as trisomy 21, where an individual has three copies of chromosome 21 instead of the usual two.

In the new study, an international team of researchers led by Professor Dean Nizetic at Barts and the London School of Medicine and Dentistry, London, UK, examined the early developmental changes that occur in the embryonic stem cell (ES cells) of mice that have been genetically engineered to carry an extra copy of human chromosome 21. They found that trisomy 21 results in a disturbance in the activity of a key regulatory gene called REST. REST controls normal development by controlling the activity of several other genes, so the disruption to REST affects the whole cascade of genetic events that occur in development. They further found that a gene on chromosome 21 called DYRK1A triggers the disturbance to REST, and that by turning off the extra copy of DYRK1A they could restore normal REST activity in the ES cells.

Down's syndrome is generally associated with slow mental and physical development, distinctive facial features, impaired cognitive abilities and learning difficulties. Other complications can include congenital heart defects, recurrent ear infections, gastrointestinal problems and early-onset dementia. Understanding how trisomy 21 leads to these conditions may lead to better treatments for them, whether they arise from Down's syndrome or from other disorders.

Prof. Nizetic said: 'We hope that further research might lead to clues for the design of new therapeutic approaches tackling developmental delay, mental retardation, ageing and regeneration of brain cells'. There may even been implications for Alzheimer's disease, as genes on chromosome 21 are thought to be involved in the progression of this disorder.

Carol Boys, Chief Executive of the Down's Syndrome Association, commented to BBC News Online: 'Any research that helps us to understand more about some of the complex medical conditions that are commonly associated with Down's syndrome can only be a positive step forward. The development of therapeutic treatments for these sometimes complicated health problems, will hopefully lead to an improvement in the overall health of people of with Down's syndrome.'

ScienceDaily | 04 September 2008
BBC News Online | 05 September 2008
CBC News | 05 September 2008


23 November 2009 - by Dr Will Fletcher 
A new drug that is being developed may lessen the effects of learning difficulties caused by the genetic condition Down's syndrome. Children with the condition are not developmentally delayed at birth, but often fall behind as they grow older because of memory deficits. A new study in mice, published in the journal Science Translational Medicine, has identified the key brain defects responsible and has pointed out a strategy for dealing with them through medication. The US resea...

08 January 2007 - by Dr Jess Buxton 
The American College of Obstetricians and Gynecologists (ACOG) has recommended that all pregnant women should be offered screening for Down syndrome, regardless of their age. Lead author Dr Deborah Driscoll said last week that 'this new recommendation says that the maternal age of 35 should no...
06 July 2006 - by Dr Jess Buxton 
US scientists have discovered that a key gene could trigger the mental impairment and early onset Alzheimer's disease associated with Down syndrome. The findings, reported in two papers published in the journal Neuron, show that the over-production of a gene involved in nerve growth can kill...
26 September 2005 - by BioNews 
UK researchers have produced a mouse with extra human genetic material that mimics Down syndrome much more accurately than previous mouse 'models' for this condition. The scientists, based at the UK's National Institute for Medical Research and the Institute of Neurology at University College London, hope the mouse will shed...
26 January 2004 - by BioNews 
Accurate prenatal tests for Down syndrome and other chromosome disorders should be made available to all pregnant women, not just those over 35, according to a new US study. Researchers at the University of California, San Francisco, evaluated the cost-effectiveness of invasive methods such as amniocentesis, and also surveyed 534...

Be the first to have your say.

You need to or  to add comments.

By posting a comment you agree to abide by the BioNews terms and conditions

- click here to enquire about using this story.

Published by the Progress Educational Trust
Advertise your products and services HERE - click for further details

Good Fundraising Code

Become a Friend of PET HERE and give the Progress Educational Trust a regular donation